12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | October 31, 2023 05:31pm

Gainers

• Plus Therapeutics (NASDAQ:PSTV) shares rose 20.3% to $1.48 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.0 million shares, which is 236.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $4.2 million. The company's, Q3 earnings came out today.
• NewAmsterdam Pharma (NASDAQ:NAMS) shares increased by 11.11% to $10.0. The company's market cap stands at $823.2 million.
• China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 10.23% to $2.37. The company's market cap stands at $1.3 million.
• DarioHealth (NASDAQ:DRIO) stock moved upwards by 7.81% to $1.38. The market value of their outstanding shares is at $37.5 million.
• Pluri (NASDAQ:PLUR) shares moved upwards by 7.75% to $0.55. The company's market cap stands at $22.5 million.
• Oncology Institute (NASDAQ:TOI) shares moved upwards by 7.32% to $2.05. The company's market cap stands at $149.5 million.

Losers

• Alaunos Therapeutics (NASDAQ:TCRT) shares declined by 7.9% to $0.07 during Tuesday's after-market session. Alaunos Therapeutics's trading volume hit 388.2K shares by close, accounting for 14.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $17.7 million.
• Blue Water Biotech (NASDAQ:BWV) shares declined by 7.44% to $0.36. The company's market cap stands at $6.4 million.
• Vaccitech (NASDAQ:VACC) shares declined by 6.32% to $3.93. The company's market cap stands at $151.6 million.
• Onconova Therapeutics (NASDAQ:ONTX) stock decreased by 5.99% to $0.6. The market value of their outstanding shares is at $12.6 million.
• Applied Molecular (NASDAQ:AMTI) shares decreased by 5.6% to $0.14. Today's trading volume for this security ended up closing at 115.0K shares, which is 10.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $5.3 million.
• NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock declined by 5.55% to $0.41. The market value of their outstanding shares is at $15.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AMTI BWV DRIO NAMS NRBO ONTX PLUR PSTV SXTC TCRT TOI VACC